ProShare Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-22,148
Closed -$2.06M 2342
2021
Q4
$2.06M Buy
22,148
+1,266
+6% +$118K ﹤0.01% 752
2021
Q3
$1.24M Sell
20,882
-5,889
-22% -$351K ﹤0.01% 837
2021
Q2
$1.83M Buy
26,771
+2,891
+12% +$197K 0.01% 757
2021
Q1
$1.66M Buy
23,880
+2,024
+9% +$140K 0.01% 764
2020
Q4
$1.68M Buy
21,856
+5,437
+33% +$418K 0.01% 688
2020
Q3
$1.23M Sell
16,419
-147
-0.9% -$11K 0.01% 666
2020
Q2
$1.04M Buy
16,566
+6,716
+68% +$423K 0.01% 695
2020
Q1
$414K Sell
9,850
-7,831
-44% -$329K ﹤0.01% 779
2019
Q4
$803K Sell
17,681
-1,496
-8% -$67.9K ﹤0.01% 879
2019
Q3
$878K Sell
19,177
-547
-3% -$25K ﹤0.01% 790
2019
Q2
$1.16M Sell
19,724
-2,475
-11% -$145K 0.01% 715
2019
Q1
$995K Buy
22,199
+238
+1% +$10.7K 0.01% 766
2018
Q4
$855K Sell
21,961
-4,238
-16% -$165K 0.01% 756
2018
Q3
$1.21M Sell
26,199
-1,032
-4% -$47.5K 0.01% 750
2018
Q2
$1.19M Buy
27,231
+2,959
+12% +$129K 0.01% 767
2018
Q1
$959K Sell
24,272
-2,717
-10% -$107K 0.01% 836
2017
Q4
$917K Buy
26,989
+2,196
+9% +$74.6K 0.01% 876
2017
Q3
$632K Buy
24,793
+5,668
+30% +$144K 0.01% 880
2017
Q2
$323K Buy
19,125
+3,316
+21% +$56K ﹤0.01% 1127
2017
Q1
$231K Sell
15,809
-4,204
-21% -$61.4K ﹤0.01% 1385
2016
Q4
$284K Buy
20,013
+2,250
+13% +$31.9K ﹤0.01% 1399
2016
Q3
$311K Sell
17,763
-3,329
-16% -$58.3K ﹤0.01% 1142
2016
Q2
$361K Buy
21,092
+153
+0.7% +$2.62K ﹤0.01% 1115
2016
Q1
$413K Sell
20,939
-2,090
-9% -$41.2K 0.01% 1079
2015
Q4
$438K Buy
23,029
+2,244
+11% +$42.7K 0.01% 1102
2015
Q3
$397K Sell
20,785
-1,609
-7% -$30.7K 0.01% 1016
2015
Q2
$1.04M Sell
22,394
-1,723
-7% -$79.9K 0.01% 758
2015
Q1
$1.05M Buy
24,117
+4,823
+25% +$211K 0.01% 822
2014
Q4
$670K Sell
19,294
-759
-4% -$26.4K 0.01% 1069
2014
Q3
$840K Sell
20,053
-4,833
-19% -$202K 0.01% 1134
2014
Q2
$1.46M Sell
24,886
-14,700
-37% -$861K 0.02% 974
2014
Q1
$2.49M Buy
39,586
+27,670
+232% +$1.74M 0.03% 617
2013
Q4
$697K Sell
11,916
-10,087
-46% -$590K 0.01% 1029
2013
Q3
$1.16M Buy
22,003
+3,234
+17% +$170K 0.03% 759
2013
Q2
$1.45M Buy
+18,769
New +$1.45M 0.03% 630